ROBERT E. CONWAY - 03 Jan 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role
Director
Signature
/s/ James Paul Rickey, attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 17:56:22 UTC
Previous filing
19 Dec 2022
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Award $0 +10,000 $0.000000 10,000 03 Jan 2023 Common Stock 10,000 $7.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F2 1/12th of the shares subject to the option become vested and exercisable on February 3, 2023 and 1/12 of the shares subject to the option shall vest monthly thereafter.